Skip to main content
. 2022 Jan 12;11(1):319–336. doi: 10.1007/s40120-021-00320-w

Table 3.

Reasons for treatment switches by 404 patients receiving fingolimod

Reason for switch N (%)
Disease activity despite fingolimod treatment 178 (44.1)
Adverse drug event 142 (35.1)
Patient request 31 (7.7)
Childbearing preference 18 (4.5)
Therapy interruption 10 (2.5)
Poor therapy adherence 6 (1.5)
Pregnancy 6 (1.5)
Other 13 (3.2)

N (%) Number of patients (proportion of patients)